Suppr超能文献

[首次通过分子生物学技术对家族性高胆固醇血症进行产前诊断]

[First prenatal diagnosis of familial hypercholesterolemia by a molecular biology technic].

作者信息

Stefanutti C, Vivenzio A

机构信息

Istituto di Terapia Medica Sistematica, Università degli Studi di Roma La Sapienza.

出版信息

Clin Ter. 1993 Aug;143(2):99-103.

PMID:7900953
Abstract

The first prenatal diagnosis for exclusion of homozygous familial hypercholesterolemia by using the so called technique of Restriction Polymorphism Fragment Length (RFLP's) on chorial villus DNA, was performed. The test was used when the mother of a seven-year-old child with homozygous familial hypercholesterolemia, became pregnant. Previous examination of DNA of both parents and of one hypercholesterolemic child, showed a mutation of the gene encoding for the synthesis of LDL-receptor. The comparison between first degree relatives RFLP's and the chorial villus RFLP's, showed the absence of a previously recognized mutation in the foetus. After a normal pregnancy, the child was born and his plasma cholesterol was within the "normal" range.

摘要

首次采用绒毛膜绒毛DNA上的限制性片段长度多态性(RFLP)技术进行产前诊断以排除纯合子家族性高胆固醇血症。该检测应用于一名患有纯合子家族性高胆固醇血症的7岁儿童的母亲怀孕时。此前对父母双方及一名高胆固醇血症患儿的DNA检测显示,编码低密度脂蛋白受体合成的基因发生了突变。通过对一级亲属的RFLP与绒毛膜绒毛的RFLP进行比较,发现胎儿不存在先前已确认的突变。经过正常妊娠,孩子出生,其血浆胆固醇处于“正常”范围。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验